Trial record 1 of 1 for:    BREAST MEDI-573
Previous Study | Return to List | Next Study

Study of MEDI-573 Plus Standard Endocrine Therapy for Women With Hormone-sensitive Metastatic Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01446159
Recruitment Status : Active, not recruiting
First Posted : October 5, 2011
Last Update Posted : May 21, 2018
Information provided by (Responsible Party):
MedImmune LLC

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : May 31, 2017
  Estimated Study Completion Date : June 8, 2018